Lymphoma D008223

Description

A general term for various neoplastic diseases of the lymphoid tissue.   MeSH

Subtype Terms (5)

Composite Lymphoma
8 drugs (7 approved, 1 experimental)

Hodgkin Disease
404 drugs (176 approved, 228 experimental)

Immunoproliferative Small Intestinal Disease
 

Intraocular Lymphoma
75 drugs (47 approved, 28 experimental)

Lymphoma, Non-Hodgkin
731 drugs (236 approved, 495 experimental)


Phase 3 Indicated Drugs (143)

Phase 2 Indicated Drugs (310)

acalabrutinib (calquence)

adavosertib

adenovirus type-5 vectored covid-19 vaccine

afatinib (gilotrif)

agatolimod

alemtuzumab (campath)

allogeneic bone marrow derived mesenchymal stem cell

allogeneic car19 regulatory t cells (car19-ttreg)

allogeneic epstein-barr virus specific cytotoxic t-lymphocytes

allogeneic stem cells

alvocidib

aminocamptothecin

aminolevulinic acid (levulan)

anakinra (kineret)

ancestim

anti-cd19/20-car vector-transduced t cells

antineoplaston a10

anti-tac(fv)-pe38

apatinib

apolizumab

arsenic trioxide (trisenox)

asp7517

atezolizumab (tecentriq)

atorvastatin (lipitor)

autologous-allogeneic tandem hematopoietic stem cell

autologous cd19/cd22 chimeric antigen receptor t-cells

autologous cd34+ cells

autologous epstein-barr virus-specific cytotoxic t lymphocytes

autologous hct

autologous hematopoietic stem cells

autologous mononuclear stem cell

autologous regulatory t cells

autologous tumor cell vaccine

autologous umbilical cord blood

auy922

avatrombopag

axicabtagene ciloleucel (Yescarta)

azd4547

azd-4547

azd-5672

azd7648

baloxavir marboxil (xofluza)

becatecarin

beclomethasone (vanceril)

belantamab mafodotin

beractant (survanta)

bevacizumab (avastin)

bi-1808

binimetinib (mektovi)

bintrafusp alfa

Bismuth Subcitrate Potassium (Pylera)

bismuth subsalicylate

blinatumomab (blincyto)

bone marrow cells

brentuximab vedotin (adcetris)

bryostatin

buparlisib

camrelizumab

capivasertib

carfilzomib (kyprolis)

car-t

cbl0137

cd19-car_lenti t cell

cd19 car-t cells

cd20 car-t cells

cd34 selected progenitor cells

cd3+ teff cells

cd7 car-t cell

celecoxib (celebrex)

chidamide

cilastatin (primaxin)

cladribine (leustatin)

clofarabine (clolar)

clr 131

cmv-specific t-cells

coh04s1

conatumumab

copanlisib (aliqopa)

Phase 1 Indicated Drugs (339)

13c-pyruvate

18f 4-l-fluoroglutamine

1928t2z car-t cell

19-28z t cells

4g7xh22

4sc-205

64cu-dota-u3-1287

9-ing-41

a27.15

abemaciclib (verzenio)

abiraterone (zytiga)

acalisib

acetic acid (vosol)

acetylcysteine (mucomyst)

actr087

actr707

adenovirus-specific t-cells

aflibercept (zaltrap)

ag-270

ag-636

alefacept (Amevive)

alfatide

alisertib

allogeneic blood cells

allogeneic cd19 car-t cells

allogeneic gamma-delta t cells

almonertinib

alpha-tea

alpn-202

altretamine (hexalen)

alvespimycin

amg-319

an4005

anti-cd19-car gamma-delta t cells

anti cd45 monoclonal antibody

ar-42

arginine

asp-3026

asp4132

at 406

at7519

autologous ade1- latent membrane protein ctls

autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes

autologous car-t

autologous cd133+ stem cells

autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells

autologous differentiated t-cells

autologous ebv specific cytotoxic t lymphocytes

autologous humanized anti-cd19 and anti-cd20 dual specific car-t cells

autologous lymphocytes

autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine

autologous mesenchymal cells

azd0466

azd-1208

azd-4877

azd5153

azd-8055

b43-genistein immunoconjugate

bardoxolone

barf1-specific cytotoxic t-lymphocytes

bcma/cd19 dual-target car-t

beta-glucans

beta-lapachone

bgb-3111

bi-2536

biib021

bl22

bmf-219

bms-986158

bms-986178

briciclib

bz019

cabazitaxel (jevtana kit)

cabiralizumab

cabozantinib (cometriq)

calaspargase pegol

camptothecin-20-o-propionate hydrate

car-37 t cells

carbendazim

carboxyamidotriazole

cb-010

cc-122

cc-220

cc-486

cc-97540


Organization Involved with Phase 4 Indications (71)

Organization Involved with Phase 3 Indications (296)

21st Century Oncology

Aarhus University

AbbVie

Acerta Pharma

Actoverco

ADC Therapeutics SARL

American Scitech International

Amgen

APHP - Hôpital Necker

Arbeitsgemeinschaft medikamentoese Tumortherapie

Archigen Biotech Limited

Aronex Pharmaceuticals

ASO SS Antonio e Biagio e C Arrigo Alessandria, Italy

AstraZeneca

Australasian Leukaemia and Lymphoma Group

Azienda Ospedaliera San Giovanni Battista

AZ Sint-Jan

Barts & The London NHS Trust

Bayer

BeiGene

Beijing InnoCare Pharma Tech Co., Ltd.

Belgian Hematological Society

Ben Gurion University

Biocad

Biovest International

Blood and Marrow Transplant Clinical Trials Network

Boehringer Ingelheim

British Columbia Cancer Agency

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Cancer Research Campaign

Cancer Research UK

Catholic University of Korea

Celgene

Celltrion

Center for International Blood and Marrow Transplant Research

Central South University

Centre Hospitalier Schaffner France

Centre Leon Berard

Centre Medical de Bligny

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Cephalon

Charles University

Children Oncology Group, USA

Children's Cancer and Leukaemia Group

Children's Cancer Group, China

Chinese Anti-Cancer Association

Chiron

CHU Henri Mondor

City of Hope National Medical Center

ClinAssess GmbH

Cohen Children's Medical Center of New York

Columbia University

Corixa

Coulter Pharmaceutical

CTI BioPharma

Czech Lymphoma Study Group

Dartmouth University

Denovo BioPharma

Department of Veteran Affairs

Dr. Reddy's Laboratories

Eastern Cooperative Oncology Group

EBMT Solid Tumors Working Party

ECOG-ACRIN Cancer Research Group

Eden Biologics

Eli Lilly

Elorac, Inc.

Emergent BioSolutions

Epizyme, Inc.

Erasmus University Rotterdam

European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma

European Mantle Cell Lymphoma Network

European Organisation for Research and Treatment of Cancer

European Union

Favrille

Fondation ARC

Fondazione Giovanni Pascale

Fondazione Italiana Diabete Onlus

Fondazione Michelangelo

Free University of Amsterdam

Free University of Brussels

French Innovative Leukemia Organisation

French Study Group on Chronic Lymphoid Leukemia

Fudan University

Fujian Medical University

Gamida Cell

Genentech

Genitope Corporation

Genmab

German Federal Ministry of Education and Research

German High-Grade Non-Hodgkin's Lymphoma Study Group

German Hodgkin's Lymphoma Study Group

German Low Grade Lymphoma Study Group

GlaxoSmithKline

Government of Canada

Government of China

Government of Japan

Government of Russia

GRADE Onlus

Grup per l'Estudi dels Limfomes de Catalunya i Balears

Gruppo Italiano Malattie EMatologiche dell'Adulto

Gruppo Italiano Studio Linfomi

Gruppo Italiano Terapie Innovative nei Linfomi

Gruppo Italiano Trapianto di Midollo Osseo

Guangxi Medical University

Guangzhou Medical University

Harvard University

Hematology Oncology Associates of the Palm Beaches

Hengrui Therapeutics, Inc.

Herbert Irving Comprehensive Cancer Center

Hoosier Cancer Research Network

HOVON - Dutch Haemato-Oncology Association

Humanitas University

ICON

Imclone

Immunomedics

Incyte

Innogene Kalbiotech Pte. Ltd

Innovent Biologics (Suzhou) Co. Ltd.

Inova Health System

Institut Bergonié

Institut Gustave Roussy

Insud Pharma

International Extranodal Lymphoma Study Group

Ipsen

Janssen Pharmaceutica NV

Japan Clinical Oncology Group

Jiangsu Cancer Institute & Hospital

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Johns Hopkins University

Kantonsspital Münsterlingen

Karolinska Institute

Karyopharm Therapeutics Inc

Katholieke Universiteit Leuven

Key Oncologics (Pty) Ltd

Kyowa Hakko Kirin

Laboratorio Elea S.A.C.I.F. y A.

Leiden University

Loxo Oncology

Loyola University

Ludwig Maximilians University

Lundbeck

Mabion SA

Maria Sklodowska Curie Children's Hospital

Mayo Clinic

McMaster University

MedCenter Primary and Internal Medicine

Medical College of Wisconsin

Medical Research Council

Medical University of South Carolina

Memorial Sloan-Kettering Cancer Center

Menoufia University

Merckle

Merck Serono

Moorgreen Hospital, Southampton

MorphoSys

Morristown Memorial Hospital

Nanjing Medical University

Nanjing Yoko Biomedical Co., Ltd.

Nanolek LLC

National Center for Research Resources (NCRR)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institutes of Health (NIH)

National Marrow Donor Program

Netherlands Cancer Institute

Newcastle University

New York Blood Center

New York University

NKBio Co.Ltd.

Nordic Lymphoma Group

Northeast Georgia Cancer Care

Northwell Health

Northwestern University

Novartis

Novo Nordisk

Oregon Health and Science University

Ospedale Centrale di Bolzano

Ospedale Civile Alessandria

Parexel

Paris Diderot University

Peter MacCallum Cancer Centre

Pirogov Russian National Research Medical University

Portola Pharmaceuticals

Probiomed S.A. de C.V.

Procter and Gamble

Radboud University

Royal Liverpool & Broadgreen University Hospitals NHS Truts

Russian Academy of Medical Sciences

Saarland University

Saitama Medical University

Sandoz

Scotland and Newcastle Lymphoma Group

Shandong Lanjin Pharmaceuticals Co.,Ltd

Shandong University

Shanghai CP Guojian Pharmaceutical Co.,Ltd.

Shanghai Henlius Biotech

Sheffield Hallam University

Shire

Sichuan University

Skåne University Hospital

Societe Francaise Oncologie Pediatrique

Soligenix

Southern Medical University

Southwest Oncology Group

Spectrum Pharmaceuticals

Sponsor GmbH

Stanford University

State University of New York, Buffalo

St. Joseph's Children's Hospital of Tampa

St. Jude Children's Hospital

Sun Yat-Sen University

Swiss Group for Clinical Cancer Research

SymBio Pharmaceuticals

Tanta University

Taunton and Somerset NHS Foundation Trust

Technical University of Dresden

Technion University

Teva

TG Therapeutics, Inc.

The Canadian Blood and Marrow Transplant Group

The Christie NHS Foundation Trust

The Lymphoma Academic Research Organisation

The Lymphoma Study Association

Thomas Jefferson University

Tianjin Medical University

Tokai University

Trans Tasman Radiation Oncology Group

UNICANCER

United Kingdom Children's Cancer Study Group

Universidad Carlos III Madrid

Universidad Complutense de Madrid

Université catholique de Louvain

University of Alabama, Birmingham

University of Amsterdam

University of Barcelona

University of Bern

University of Birmingham

University of Brescia

University of Burgundy

University of Caen-Normandie

University of California, Los Angeles

University of California, San Francisco

University of Cambridge

University of Cincinnati

University of Cologne

University of Copenhagen

University of Duisburg-Essen

University of Erlangen-Nuremberg

University of Freiburg

University of Goettingen

University of Grenoble

University of Groningen

University of Hamburg

University of Heidelberg

University of Lausanne

University of Leeds

University of Leipzig

University of Liege

University of Liverpool

University of Lyon

University of Manchester

University of Messina

University of Michigan

University of Milan

University of Modena and Reggio Emilia

University of Munster

University of Nagasaki

University of Nebraska

University of North Carolina at Chapel Hill

University of Nottingham

University of Paris

University of Pennsylvania

University of Plymouth

University of Reims

University of Rochester

University of Sheffield

University of South Florida

University of Sydney

University of Toronto

University of Turin

University of Ulsan

University of Vienna

University of Washington

University of Wisconsin

U.O.A. di Ematologia Azienda Ospedale S. Maria Nuova

U.O.A. di Ematologia Ospedale Molinette

Uppsala University

US Oncology

Utrecht University

Verastem, Inc.

Virginia Commonwealth University

Wake Forest University

Washington University in St. Louis

West Virginia University

Xinjiang Medical University

Organization Involved with Phase 2 Indications (631)

4SC AG

Aalborg University

Abbott

Academic and Community Cancer Research United

Acetylon Pharmaceuticals Incorporated

Acibadem University

Actuate Therapeutics Inc.

Adienne SA

Aegera Therapeutics

AEterna Zentaris

Affimed GmbH

Agenus Inc.

Agios Pharmaceuticals, Inc.

AIDS Malignancy Consortium

Aileron Therapeutics

Akeso Pharmaceuticals, Inc.

Albany Medical College

Alberta Cancer Foundation

Alliance Foundation Trials

All India Institute of Medical Sciences

Allogene Therapeutics

Alopexx

Altor Bioscience

American Cancer Society, Inc.

American College of Radiology

American Society of Clinical Oncology

Angimmune LLC

AnorMED

Apogee Biotechnology Corporation

Aprea Therapeutics AB

Ariad Pharmaceuticals

Arizona Oncology Associates

Array BioPharma

Artiva Biotherapeutics, Inc.

Asana BioSciences

Ascenta Therapeutics

Asociacion Doctor Peset Para el Estudio de la Hematología

Assisi Foundation

Assistance Publique - Hôpitaux de Paris

Astellas

Astex Pharmaceuticals, Inc.

Atara Biotherapeutics

Autolus Limited

Auxilio

Azienda Ospedaliera Antonio Cardarelli

Azienda Ospedaliera S. Croce e Carle Cuneo

Azienda Osperdaliera Vincenzo Cervello Divisione

Basque Country University

Baylor University

Beijing Biohealthcare Biotechnology Co.,Ltd

Beijing Longfu Hospital

Beijing Mabworks Biotech Co., Ltd.

Besins Healthcare

Big Ten Cancer Research Consortium

BioCryst

BioInvent International AB

BioLineRx, Ltd.

Biologics, Inc.

Biothera

Bloodwise

Boca Raton Clinical Research Associates

Boryung Pharmaceutical Company

Bronx River Medical Associates, PC

Brown University

Burroughs Wellcome

Burzynski Research Institute

CABYC

Cancer Biotherapy Research Group

Cancer Care Centers of South Texas , San Antonio

Cancer Care Clinic and Hospital, Nagpur, India

Cancer Treatment Centers of America

Cantonal Hospital of St. Gallen

Capital Medical University

CARsgen Therapeutics, Ltd.

Cascade Cancer Center

Cedars-Sinai Medical Center

Celimmune

Celldex Therapeutics

Cellectar, Inc

Celleron Therapeutics Ltd.

Centaurus Biopharma Co., Ltd.

Central Maryland Oncology Center

Centre Henri Becquerel

Centre Hospitalier ABBEVILLE

Centre Hospitalier COMPIEGNE

Centro di Riferimento Oncologico - Aviano

Centro Goiano de Oncologia

Centro Medico Nacional La Raza, IMSS

CerRx, Inc.

Chang Gung University

Changhua Christian Hospital

Checkmate Pharmaceuticals

Children's National Medical Center

Chimei Medical Center

China Food and Drug Administration

China Medical University

Chipscreen Biosciences, Ltd.

Chonbuk National University

Chongqing Medical University

Chongqing Precision Biotech Co., Ltd

Chonnam National University

CHU Brabois

Chugai

CHU Hart Leveque

Chulalongkorn University

CHU La Timone

CHU Mont-Godinne

Chung-Ang University

Chungnam National University

City Hospital Triemli

Ciusss de L'Est de l'Île de Montréal

Clinical Center Kragujevac

Clinical Center Nis

Clinica Universidad de Navarra

Complessa di Ematologia and Dir Departmento

Consortium for Improving Survival of Lymphoma

Constant Pharmaceuticals

Cookies for Kids' Cancer

CRISPR Therapeutics

CSL Behring

CStone Pharmaceuticals

CureTech Ltd

Curie Institute

Curis

Cyclacel Pharmaceuticals, Inc.

Cyteir Therapeutics, Inc.

Cytokinetics

CytomX Therapeutics

Daiichi Sankyo

Dalian Medical University

Damon Runyon Cancer Research Foundation

Danish Child Cancer Foundation

Department of Lymphoma and Hematology, Hunan Cancer Hospital

Deutsche AIDS Gesellschaft e.V.

Developmental Therapeutics Consortium

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology

Dong-A University

Dr. Bernard Verbeeten Instituut

Drs Pirjol, Szpak and Moodley Inc, Durban, South Africa

Duke University

Duran i Reynals Hospital

Dynamic Science S.L.

Dynavax Technologies Corporation

Eleos, Inc.

Emory University

Enzon

EORTC Lymphoma Group

Eutilex

Facet Biotech

Faculdade de Medicina do ABC

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Federal University of Rio Grande do Sul

Florida Academic Dermatology Centers

Food and Drug Administration

Fortress Biotech

Forty Seven, Inc.

Foshan First People's Hospital

Franklin Square Hospital Center

Free State University

French National Agency for Research on AIDS and Viral Hepatitis

Fujifilm

Fundacao Hospital Amaral Carvalho

Fundación Hospital Alcorcón

Fundación Leucemia y Linfoma, Spain

Gabrail Cancer Center

Gachon University

Galderma

Garden State Cancer Center

Gateway for Cancer Research

Gemeinschaftspraxis Porowski & Koniczek, Heilbronn, Germany

Gemin X

Genor BioPharma Co., Ltd.

Genta

Georgetown University

George Washington University

Geriatric Oncology Consortium

German Society of Cancer e.V.

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Gloucester Pharmaceuticals

GLyPharma Therapeutic

GMP BIO Co., LTD.

Government of Belgium

Government of Brazil

Government of France

Government of Saudi Arabia

Government of Singapore

Government of Taiwan

Green Cross Corporation

Groupe Hospitalier Public Sud Oise

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas

Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie

GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI

Guangzhou Gloria Biosciences Co., Ltd.

GWT-TUD GmbH

Gyeongsang University

Hallym University

Hangzhou Zenshine Pharmaceuticals Co., Ltd.

Hebei University

Hebrew University

Hefei University

Henan University of Traditional Chinese Medicine

Henry Ford Health System

Hoag Memorial Hospital Presbyterian

Hopital A Beclere Clamart

Hôpital Maisonneuve Rosemont, Montréal, QC, Canada

Hospital Auxilio Mutuo

Hospital Avicenne

Hospital Brigadeiro

Hospital Carlos Haya

Hospital Center of Périgueux

Hospital Center Saint-Quentin

Hospital Clinico Lozano Blesa

Hospital de Clinicias da UICAMP

Hospital de Galdakao

Hospital de Getafe

Hospital de Jerez

Hospital del SAS de Jerez

Hospital de Segovia

Hospital Dr. Jose Molina Orosa

Hospital Duran i Reynals

Hospital Erasto Gaertner

Hospital Fundación de Alcorcon

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Hospital Jerez de la Frontera

Hospital Morales Meseguer

Hospital Nossa Senhora da Conceicao

Hospital Santa Marcelina, Sao Paulo, Brasil

Hospital Severo Ochoa

Hospital Son Espases

Hospital Txagorritxu

Hospital Universitario Arnau de Vilanova de Lleida

Hospital Universitario Central de Asturias

Hospital Universitario Puerta del Mar

Hospital Universitari Son Dureta

Hospital Virgen de la Concha

Huizhou People's Central Hospital

Human Genome Sciences

Humanigen

Hutchison MediPharma

HUYA Bioscience International

Icahn School of Medicine at Mount Sinai

ICO Hospital Durans i Reynals

Idera

Imagine Institute

Imamura Bun-in Hospital

Immune Design

ImmuneOncia Therapeutics Inc.

ImmunogenX

ImmunoVaccine Technologies, Inc.

Immunovative Therapies

Indiana University

Inex Pharmaceuticals

Inje University

Innate Pharma

Innovative Cellular Therapeutics Co., Ltd.

Innovative Therapies For Children with Cancer Consortium

Institut Català d'Oncologia, Hospital Duran i Reynals

Institute for Oncology and Radiology Serbia

Instituto de Oncologia Pediatrica - GRAACC Grupo de Apoio as Adolescente e a Crianca com Cancer - UNIFESP

Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti

Institut Paoli-Calmettes

Instytut Hematologii i Transfuzjologii, 02-776 Warszawa ul. Indiry Gandhi 14

InterMune

Inveresk Research

Iovance

IQVIA

Isala Clinics, Zwolle, The Netherlands

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istitutp di Ematologia ed Oncologia Medica

Italfarmaco

Italian Lymphoma Foundation

Jaen Hospital

James Graham Brown Cancer Center

Jaslok Hospital and Research Centre, Mumbai, India

Jazz Pharmaceuticals

Jerez Hospital

Jiangxi Provincial Cancer Hospital

Jichi Medical University

Jilin University

Jinan University

Jinlin University

Johannes Gutenburg University

Johannes Wesling Klinikum, Minden, Germany

Josep Carreras Leukaemia Research Institute

JSS Medical Research Inc.

Julius-Maximilians University

Juno Therapeutics, Inc.

Juventas Therapeutics, Inc.

Kahr Medical

Kangbuk Samsung Hospital

Kansas Bioscience Authority

Kantonsspital Aarau

Kantonsspital Graubünden

Kaohsiung Medical University

Kartos Therapeutics, Inc.

Kecellitics Biotech Company Ltd

Keimyung University

Keio University

Kepler University

Keryx

King Abdullah Medical City

Kite Pharma, Inc.

Klinika Okulistyki

Klinikum Minden

Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien

Korea Cancer Center Hospital

Korea Research Institute of Bioscience & Biotechnology

Korea University

Kosin University

Kumamoto University

Kura Oncology, Inc.

Kuur Therapeutics

Kyungpook University

La Jolla Pharmaceutical Company

Leadiant Biosciences, Inc.

Lederle

León Hospital

Leo Pharma

Liberty Hematology and Oncology

LifeBridge Health

LifeTime Pharmaceuticals

Linkoping University

Lipomed

Louisiana State University

Ludaopei Hospital

Lund University

Lymphoma Disease Committee of TCOG

Lymphoma Research Foundation

Mackay Medical College

Mahidol University

Malabar Institute of Medical Sciences

Mansoura University

Marche Polytechnic University

Mario Negri Institute

McGill University

Medical City Children's Hospital, Dallas

Medical University of Vienna

MedImmune

Medivation

Meenakshi Ammal Dental College and Hospital

MEI Pharma

Memgen, LLC

Merck KGaA

Mesoblast, Inc.

Methodist Cancer Center, Houston, Texas

MethylGene Inc.

Millennix

Miltenyi Biotec, Inc.

miRagen Therapeutics, Inc.

Mirati Therapeutics Inc.

Molecular Templates

MolMed S.p.A.

Monash University

Morales i Meseguer Hospital

Mutua de Terrassa Hospital

Nanchang University

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Nanjing University

NantCell, Inc.

National Cancer Center, Korea

National Cancer Institute, France

National Cheng Kung University

National Comprehensive Cancer Network

National Institute on Aging (NIA)

National Natural Science Foundation of China

National University of Singapore

Neumedicines Inc.

New York Medical College

Nordic Nanovector

Nordic Society for Pediatric Hematology and Oncology

North Central Cancer Treatment Group

Northern Italy Leukemia Group

Northside Hospital, Inc.

Norwegian Cancer Society

Norwegian University of Science and Technology

Norwood Immunology Limited

Novacea

NRG Oncology

Ohio State University

OHSU Knight Cancer Institute

Okayama University

Oncoceutics, Inc.

Oncology Specialists, S.C.

OncoSec Medical Incorporated

Ono Pharmaceuticals

Onxeo

Onyx

Ortho Biotech, Inc.

Osaka University

Ospedale degli Infermi di Biella

Ospedale Maggiore Azienda Sanitaria Universitaria Trieste Ematologia

Ospedale Santa Croce-Carle Cuneo

Ospedale S. Giovanni Bellinzona

Otsuka

Our Lady of Mercy Medical Center

Ozmosis Research Inc.

Pardee Foundation

Pavlov First Saint Petersburg State Medical University

PDL BioPharma

Pennsylvania State University

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

PharmaMar

Pharmatech

Philipps University of Marburg

Philogen S.p.A.

Pierre Fabre

PIQUR Therapeutics AG

Piramal

Pivotal S.L.

Plexxikon

Polaris Group

Precision BioSciences, Inc.

PrECOG, LLC.

Pretoria Academic Hospital

Prologue Research International

Pusan National University

Quebec Clinical Research Organization in Cancer

Radiation Therapy Oncology Group

Raffles Hospital, Singapore

Rajiv Gandhi University of Health Sciences

RedHill Biopharma

Regeneron

Regional Hospital of Bolzano

Rhizen Pharmaceuticals SA

Rhode Island Hospital

Rigel Pharmaceuticals

Rochester Skin Lymphoma Medical Group, PLLC

Rongjie Tao

Royal Marsden Hospital NHS Trust

Rutgers University

RWTH Aachen University

Samsung Medical Center

Samyang Biopharmaceuticals Corporation

San Bortolo Hospital, Vicenza

San Giuseppe Moscati Hospital

Sanofi-Synthelabo

S*BIO

Scott and White Healthcare

SCRI Development Innovations

Scripps

Segovia Hospital

Service Clinique des Maladies du Sang

Sevion Therapeutics

Shandong New Time Pharmaceutical Co., LTD

Shanghai Ming Ju Biotechnology Co., Ltd.

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Shanghai YingLi Pharmaceutical Co. Ltd.

Shantou University

Shenzhen BinDeBio Ltd.

Shenzhen Geno-Immune Medical Institute

Shenzhen Hank Bioengineering Institute

Shenzhen University

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Sierra Oncology, Inc.

Simcere Pharmaceutical Co., Ltd

Singapore General Hospital

Sinocelltech Ltd.

Siriraj Hospital

Sirna Therapeutics

Solasia Pharma K.K.

Son Llatzer Hospital

Soochow University

Soonchunhyang University

Sorrento Therapeutics, Inc.

Southampton University Hospital NHS Foundation Trust

South-Eastern Norway Regional Health Authority

Southern Europe New Drug Organization (SENDO)

Spanish National Health System

State University of New York, Syracuse

St. Baldrick's Foundation

St. Bortolo Hospital

Stellenbosch University

St. John Hospital and Medical Center, Van Elslander Cancer Center

Stony Brook University

Sunesis Pharmaceuticals

Sungkyunkwan University

Swedish Cancer Institute

Syndax Pharmaceuticals

Systemix

Szpital Morski im. PCK

Taichung Veterans General Hospital

TaiGen Biotechnology Co., Ltd.

Takara Bio Inc.

Takeda

Tanox

Targazyme, Inc.

Tata Memorial Hospital

Tayu Huaxia Biotech Medical Group Co., Ltd.

TCR2 Therapeutics

Technical University of Munich

Telik

Temple University

Territorial Hospital Group (GHT) Rance Emeraude

Tesaro

Tessa Therapeutics

TetraLogic Pharmaceuticals

The Alfred Hospital

The Alvin and Lois Lapidus Cancer Institute

The Beijing Pregene Science and Technology Company, Ltd.

The EMMES Corporation

The Foundation Institute San Raffaele G. Giglio of Cefalù

The Leukemia and Lymphoma Society

The National Cancer Center

Theradex

Thermo Fisher Scientific

The Scientific and Technological Research Council of Turkey

The Thai Lymphoma Study Group

The Wayne D. Kuni and Joan E. Kuni Foundation

Tibotec

Timmune Biotech Inc.

Transgene

Translational Research Institute for Metabolism and Diabetes, Florida

Trinity Health of New England

Triumvira Immunologics, Inc.

Tularik

Tzu Chi University

Umea University

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

Universidad Autonoma de Nuevo Leon

Universidad de Murcia

Universidade Federal do Parana

Universitario de Santiago, Spain

University Alicante

University Clermont Auvergne

University Hospital Plymouth NHS Trust

University of Alberta

University of Arizona

University of Bordeaux

University of Cagliari

University of Calgary

University of California, Davis

University of California, Irvine

University of California, San Diego

University of Cantabria

University of Cape Town

University of Chicago

University of Colorado, Denver

University of Duesseldorf

University of Exeter

University of Florence

University of Florida

University of Genoa

University of Glasgow

University of Haifa

University of Helsinki

University of Illinois at Chicago

University of Iowa

University of Kansas

University of Kentucky

University of Las Palmas de Gran Canaria

University of Leicester

University of Lille

University of Limoges

University of Lorraine

University of Louisville

University of Magdeburg

University of Mannheim

University of Massachusetts

University of Medicine and Dentistry of New Jersey

University of Melbourne

University of Miami

University of Milano Bicocca

University of Miyazaki

University of Montpellier

University of Montreal

University of Nantes

University of New Mexico

University of Nice Sophia Antipolis

University of Oslo

University of Ottawa

University of Oxford

University of Palermo

University of Pavia

University of Picardie Jules Verne

University of Poitiers

University of Regensburg

University of Rennes

University of Roma La Sapienza

University of Salamanca

University of Santiago

University of Sao Paulo

University of Sarajevo

University of Sherbrooke

University of Southern California

University of Southern Denmark

University of Strasbourg

University of Stuttgart

University of Texas, San Antonio

University of the Republic of Srpska

University of Tokyo

University of Toulouse

University of Turku

University of Udine

University of Ulm

University of Utah

University of Valencia

University of Vermont

University of Virginia

University of Western Brittany

University of Witten/Herdecke

University of Zagreb

University of Zaragoza

University of Zurich

Upjohn

VentiRx Pharmaceuticals Inc.

Vical

ViGenCell Inc.

Vion Pharmaceuticals

Virgen de la Concha Hospital

Virginia Mason Medical Center

Vita-Salute University of Milano. Italy

Wayne State University

Wonju Christian Hospital

Wyeth

Xcyte Therapies

Xeme Biopharma Inc.

Xoma

Xuzhou Medical University

Xynomic Pharmaceuticals, Inc.

Yeshiva University

Yiling Pharmaceutical Inc.

Yonsei University

Zhangzhou Municipal Hospital of Fujian Province

Zhejiang DTRM Biopharma

Zhejiang Hisun Pharmaceutical Co. Ltd.

Ziopharm

Organization Involved with Phase 1 Indications (210)

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Acea Bio

Adagene Inc

Adastra Pharmaceuticals

Aduro BioTech

Aeon Therapeutics (Shanghai) Co., Ltd.

Allife Medical Science and Technology Co., Ltd.

Alphamab Co., Ltd.

ALX Oncology

Angiocrine Bioscience

Antengene Corporation

Applied Molecular Evolution

Aptevo Therapeutics

Aptose Biosciences Inc.

Arno Therapeutics

ArQule

Ascentage Pharma Group Inc.

Augusta University

Austin Health

Australian Department of Industry, Tourism and Resources

AVEO Pharmaceuticals

Baili Pharmaceutical Group

Beijing Doing Biomedical Co., Ltd.

Beijing GD Initiative Cell Therapy Technology Co.,Ltd.

Beijing Immunochina Medical Science & Technology Co., Ltd.

Bellicum Pharmaceuticals

Bharath Hospital and Institute of Oncology

Bio-Cancer Treatment International Limited

Biointegrator LLC

Bio-Path Holdings, Inc.

Biotec Pharmacon ASA

British Society for Haematology

Cabrini Hospital (Melbourne)

California Institute for Biomedical Research

California Institute for Regenerative Medicine (CIRM)

Cambridge Antibody Technology

Cancer Centres of the Carolinas, Greenville, SC 29605

Cancer Immunotherapy Trials Network

Cao Pharmaceuticals Inc.

Caribou Biosciences

Cascadian Therapeutics Inc.

Celator Pharmaceuticals

Cellerant Therapeutics

Cellular Biomedicine Group Ltd.

Centocor

Children's Hospital Los Angeles

Chiltern International

China Immunotech

Chong Kun Dang Pharmaceutical

Cho Pharma Inc.

Christus Stehlin Foundation for Cancer Research

City University of Hong Kong

Clinipace LTD

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.